A proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer

[1]  B. de Strooper,et al.  The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics , 2022, Nature Reviews Drug Discovery.

[2]  S. Hornemann,et al.  Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies , 2021, Science advances.

[3]  P. Laurent-Puig,et al.  The Cellular Prion Protein and the Hallmarks of Cancer , 2021, Cancers.

[4]  P. Laurent-Puig,et al.  Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype , 2021, Oncoimmunology.

[5]  B. de Strooper,et al.  The β-Secretase BACE1 in Alzheimer’s Disease , 2020, Biological Psychiatry.

[6]  Kelly V. Ruggles,et al.  Melanoma-secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis , 2019, bioRxiv.

[7]  P. Laurent-Puig,et al.  The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer , 2019, EBioMedicine.

[8]  K. Qin,et al.  “Dual Disease” TgAD/GSS mice exhibit enhanced Alzheimer’s disease pathology and reveal PrPC-dependent secretion of Aβ , 2019, Scientific Reports.

[9]  L. Magnani,et al.  Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts , 2019, Nature Communications.

[10]  A. Villers,et al.  Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  K. Kirshenbaum,et al.  Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrPSc and Targeting PrPSc for Lysosomal Degradation , 2018, Molecular Neurobiology.

[12]  Menggang Yu,et al.  Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy , 2017, JAMA oncology.

[13]  Yiling Lu,et al.  Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.

[14]  N. Hooper,et al.  Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype , 2016, PloS one.

[15]  S. Stewart,et al.  Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer , 2016, The Journal of experimental medicine.

[16]  Yue Lu,et al.  Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer , 2016, Nature Communications.

[17]  Joshua M. Stuart,et al.  A basal stem cell signature identifies aggressive prostate cancer phenotypes , 2015, Proceedings of the National Academy of Sciences.

[18]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[19]  M. Verbeek,et al.  Dickkopf‐related protein 3 is a potential Aβ‐associated protein in Alzheimer's Disease , 2015, Journal of neurochemistry.

[20]  Andreas Heger,et al.  Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy , 2014, European urology.

[21]  S. Love,et al.  Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage , 2013, PloS one.

[22]  G. Breen,et al.  Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway , 2012, Molecular Psychiatry.

[23]  Josephine A. Wright,et al.  Prion protein expression alters APP cleavage without interaction with BACE-1 , 2012, Neurochemistry International.

[24]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[25]  N. Hooper,et al.  Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein* , 2011, The Journal of Biological Chemistry.

[26]  Adriano Aguzzi,et al.  Prions: protein aggregation and infectious diseases. , 2009, Physiological reviews.

[27]  David R. Brown,et al.  The effects of prion protein expression on metal metabolism , 2009, Molecular and Cellular Neuroscience.

[28]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[29]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[30]  N. Hooper,et al.  Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein , 2007, Proceedings of the National Academy of Sciences.

[31]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[32]  S. Martin-Lannerée,et al.  Functions of the Prion Protein. , 2017, Progress in molecular biology and translational science.